Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1983 Apr;17(4):619–624. doi: 10.1128/jcm.17.4.619-624.1983

Limitations of available tests for diagnosis of infectious mononucleosis.

G R Fleisher, M Collins, S Fager
PMCID: PMC272704  PMID: 6304142

Abstract

Among 500 students seen at a university health service for illnesses resembling infectious mononucleosis (IM), the diagnosis of IM was established in 124 (25%) on the basis of the initial presence or subsequent emergence of the spectrum of Epstein-Barr virus (EBV) antibodies characteristic of a primary EBV infection. Of these 124 patients, 113 had an EBV-specific antibody pattern in the initial serum indicative of current primary infection; however, 11 (9%) had no detectable immunoglobulin G antibodies to EBV-specific antigens in their first serum. The sensitivity of this panel of EBV antibody assays was 91% and the specificity was 100%. Initial sera had detectable heterophil antibodies for 107 (86%) of the 124 students with IM and for 2 with other illnesses. Among our patients, the Monospot (Ortho Diagnostics Inc.) test had a sensitivity of 86% and a specificity of 99%. Reliance on hematological criteria (lymphocyte count greater than or equal to 50% and atypical lymphocyte count greater than or equal to 10%) gave a sensitivity of only 39%, but a specificity of 99%. Students with IM who showed a delayed emergence of the spectrum of EBV-specific antibodies characteristic of an acute infection were compared with control patients who had such antibodies at the time of their initial visit to the health service. They were found to have a briefer duration of illness (P greater than 0.05), lower leukocyte (P less than 0.005), lymphocyte (P less than 0.005), and atypical lymphocyte (P less than 0.05) counts, and a less frequent occurrence of heterophil antibodies (P less than 0.05).

Full text

PDF
619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Evans A. S., Niederman J. C., Cenabre L. C., West B., Richards V. A. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975 Nov;132(5):546–554. doi: 10.1093/infdis/132.5.546. [DOI] [PubMed] [Google Scholar]
  2. Fleisher G., Lennette E. T., Henle G., Henle W. Incidence of heterophil antibody responses in children with infectious mononucleosis. J Pediatr. 1979 May;94(5):723–728. doi: 10.1016/s0022-3476(79)80138-9. [DOI] [PubMed] [Google Scholar]
  3. Hallee T. J., Evans A. S., Niederman J. C., Brooks C. M., Voegtly j. H. Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years. Yale J Biol Med. 1974 Sep;47(3):182–195. [PMC free article] [PubMed] [Google Scholar]
  4. Heath C. W., Jr, Brodsky A. L., Potolsky A. I. Infectious mononucleosis in a general population. Am J Epidemiol. 1972 Jan;95(1):46–52. doi: 10.1093/oxfordjournals.aje.a121369. [DOI] [PubMed] [Google Scholar]
  5. Henke C. E., Kurland L. T., Elveback L. R. Infectious mononucleosis in Rochester, Minnesota, 1950 through 1969. Am J Epidemiol. 1973 Dec;98(6):483–490. doi: 10.1093/oxfordjournals.aje.a121577. [DOI] [PubMed] [Google Scholar]
  6. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henle W., Henle G. E., Horwitz C. A. Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol. 1974 Sep;5(5):551–565. doi: 10.1016/s0046-8177(74)80006-7. [DOI] [PubMed] [Google Scholar]
  9. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970 Jul 10;169(3941):188–190. doi: 10.1126/science.169.3941.188. [DOI] [PubMed] [Google Scholar]
  10. Joncas J., Chiasson J. P., Turcotte J., Quennec P. Studies on infectious mononucleosis. 3. Clinical data, serologic and epidemiologic findings. Can Med Assoc J. 1968 May 4;98(18):848–854. [PMC free article] [PubMed] [Google Scholar]
  11. Lennette E. T., Henle G., Henle W., Horwitz C. A. Heterophil antigen in bovine sera detectable by immune adherence hemagglutination with infectious mononucleosis sera. Infect Immun. 1978 Mar;19(3):923–927. doi: 10.1128/iai.19.3.923-927.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  13. Sawyer R. N., Evans A. S., Niederman J. C., McCollum R. W. Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis. J Infect Dis. 1971 Mar;123(3):263–270. doi: 10.1093/infdis/123.3.263. [DOI] [PubMed] [Google Scholar]
  14. Schmitz H., Scherer M. IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Gesamte Virusforsch. 1972;37(4):332–339. doi: 10.1007/BF01241456. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES